{"schema_version":"1","generated_at":"2026-10-30T09:54:12.155Z","data_as_of":null,"url":"https://www.findmykol.com/kol/mikael-rinne","json_url":"https://www.findmykol.com/kol/mikael-rinne/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"mikael-rinne","name":"Mikael Rinne","credential":"MD, PhD","specialty":"Neurology","specialty_raw":"Neurology","therapeutic_area":"Neurology","therapeutic_areas":["Neurology"],"city":"Boston","state":"MA","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1285838185","orcid":"0009-0006-6764-9404","openalex":"A5015677091"},"summary":"Mikael Rinne is a Neurology physician. OpenAlex indexes 86 publications with 3,265 citations (h-index 30).","overview":null,"focus":{"indications":[],"research_topics":["Neurology"]},"scholarship":{"works_count":86,"cited_by_count":3265,"h_index":30,"latest_activity_year":2025,"source":"works"},"payments":{"company_count":2,"program_years":{"first":2021,"last":null},"rows_total":5,"shown":3,"withheld":2,"rows":[{"payer":"QIAGEN, LLC","program_year":2025,"amount_usd":28800,"payment_count":12,"source_url":"https://openpaymentsdata.cms.gov/search?query=1285838185"},{"payer":"QIAGEN, LLC","program_year":2024,"amount_usd":28800,"payment_count":11,"source_url":"https://openpaymentsdata.cms.gov/search?query=1285838185"},{"payer":"QIAGEN, LLC","program_year":2023,"amount_usd":28800,"payment_count":11,"source_url":"https://openpaymentsdata.cms.gov/search?query=1285838185"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1285838185","source":"payments"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"CDK2 inhibition enhances CDK4/6 inhibitor antitumor activity in comprehensive breast cancer PDX model screen","year":2025,"journal":"npj Breast Cancer","source_url":"https://doi.org/10.1038/s41523-025-00851-7","status":"verified"},{"title":"Inaugural Results of the Individualized Screening Trial of Innovative Glioblastoma Therapy: A Phase II Platform Trial for Newly Diagnosed Glioblastoma Using Bayesian Adaptive Randomization","year":2023,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.23.00493","status":"verified"},{"title":"Phase Ib study of sabatolimab (<scp>MBG453</scp>), a novel immunotherapy targeting <scp>TIM‐3</scp> antibody, in combination with decitabine or azacitidine in high‐ or very high‐risk myelodysplastic syndromes","year":2023,"journal":"American Journal of Hematology","source_url":"https://doi.org/10.1002/ajh.27161","status":"verified"},{"title":"Sabatolimab (<scp>MBG453</scp>) model‐informed drug development for dose selection in patients with myelodysplastic syndrome/acute myeloid leukemia and solid tumors","year":2023,"journal":"CPT Pharmacometrics & Systems Pharmacology","source_url":"https://doi.org/10.1002/psp4.12962","status":"verified"},{"title":"Characterization of sabatolimab, a novel immunotherapy with immuno-myeloid activity directed against TIM-3 receptor","year":2022,"journal":"Immunotherapy Advances","source_url":"https://doi.org/10.1093/immadv/ltac019","status":"verified"}],"source":"works"},"contact":{"address_1":"450 BROOKLINE AVE","city":"Boston","state":"MA","zip":"022155418","phone":"617-632-2166","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1285838185","source":"identity"},"similar":[{"name":"Bruce Miller","slug":"bruce-miller","institution":"University of California, San Francisco (UCSF)","specialty":"Neurology","url":"https://www.findmykol.com/kol/bruce-miller","json_url":"https://www.findmykol.com/kol/bruce-miller/profile.json"},{"name":"Brett Kissela","slug":"brett-kissela","institution":"Medical College of Wisconsin","specialty":"Neurology","url":"https://www.findmykol.com/kol/brett-kissela","json_url":"https://www.findmykol.com/kol/brett-kissela/profile.json"},{"name":"Bradley Boeve","slug":"bradley-boeve","institution":"Mayo Clinic","specialty":"Neurology","url":"https://www.findmykol.com/kol/bradley-boeve","json_url":"https://www.findmykol.com/kol/bradley-boeve/profile.json"},{"name":"Richard Lipton","slug":"richard-lipton","institution":"Albert Einstein College of Medicine","specialty":"Neurology","url":"https://www.findmykol.com/kol/richard-lipton","json_url":"https://www.findmykol.com/kol/richard-lipton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":2,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2011-08-01","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}